{
  "guid": "CBMiowJBVV95cUxPeEtqeWhuRzl2bW0xT282c0E0T3FGOUxnVWdYcnRYTVFVRVh2dE9MZUZ3dHl3RktWSHh2cm5XME93MGU5OWVCVFlTQ3ZTMjB4WlpIX3FNRF9CemQwbkY2RmFJZy15QVBIWkNJRzRBTjVxY1l4U19Jcjd4eFVnYkJQMi1TYVZhbXI2SnVfYjQ4d3lEaE5xQlFiQlNRdVlYRGNWZFRvcjAwbnRzWmxwVTJLZklvd2hHcmhCaVhabWdHY0QtN2V2M0hNTzVpMko1TlgxTzl4QWtHZk9BenFGS3JBSVVJaGU5VS1KV0Q2Qm41YUJJZ21KTGdkck00RDlvaVRkcjdDU1gtNmpmZmE3ZXYxNnJKZmZ3SFdhQm9Za3ZmMFZlOU0",
  "title": "<h1><a href=\"https://news.google.com/rss/articles/CBMiowJBVV95cUxPeEtqeWhuRzl2bW0xT282c0E0T3FGOUxnVWdYcnRYTVFVRVh2dE9MZUZ3dHl3RktWSHh2cm5XME93MGU5OWVCVFlTQ3ZTMjB4WlpIX3FNRF9CemQwbkY2RmFJZy15QVBIWkNJRzRBTjVxY1l4U19Jcjd4eFVnYkJQMi1TYVZhbXI2SnVfYjQ4d3lEaE5xQlFiQlNRdVlYRGNWZFRvcjAwbnRzWmxwVTJLZklvd2hHcmhCaVhabWdHY0QtN2V2M0hNTzVpMko1TlgxTzl4QWtHZk9BenFGS3JBSVVJaGU5VS1KV0Q2Qm41YUJJZ21KTGdkck00RDlvaVRkcjdDU1gtNmpmZmE3ZXYxNnJKZmZ3SFdhQm9Za3ZmMFZlOU0?oc=5\" target=\"_blank\">ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA - Business Wire</a></h1>",
  "link": "https://news.google.com/rss/articles/CBMiowJBVV95cUxPeEtqeWhuRzl2bW0xT282c0E0T3FGOUxnVWdYcnRYTVFVRVh2dE9MZUZ3dHl3RktWSHh2cm5XME93MGU5OWVCVFlTQ3ZTMjB4WlpIX3FNRF9CemQwbkY2RmFJZy15QVBIWkNJRzRBTjVxY1l4U19Jcjd4eFVnYkJQMi1TYVZhbXI2SnVfYjQ4d3lEaE5xQlFiQlNRdVlYRGNWZFRvcjAwbnRzWmxwVTJLZklvd2hHcmhCaVhabWdHY0QtN2V2M0hNTzVpMko1TlgxTzl4QWtHZk9BenFGS3JBSVVJaGU5VS1KV0Q2Qm41YUJJZ21KTGdkck00RDlvaVRkcjdDU1gtNmpmZmE3ZXYxNnJKZmZ3SFdhQm9Za3ZmMFZlOU0?oc=5",
  "pubDate": "Tue, 20 Jan 2026 09:00:00 GMT",
  "description": "<li><a href=\"https://news.google.com/rss/articles/CBMiowJBVV95cUxPeEtqeWhuRzl2bW0xT282c0E0T3FGOUxnVWdYcnRYTVFVRVh2dE9MZUZ3dHl3RktWSHh2cm5XME93MGU5OWVCVFlTQ3ZTMjB4WlpIX3FNRF9CemQwbkY2RmFJZy15QVBIWkNJRzRBTjVxY1l4U19Jcjd4eFVnYkJQMi1TYVZhbXI2SnVfYjQ4d3lEaE5xQlFiQlNRdVlYRGNWZFRvcjAwbnRzWmxwVTJLZklvd2hHcmhCaVhabWdHY0QtN2V2M0hNTzVpMko1TlgxTzl4QWtHZk9BenFGS3JBSVVJaGU5VS1KV0Q2Qm41YUJJZ21KTGdkck00RDlvaVRkcjdDU1gtNmpmZmE3ZXYxNnJKZmZ3SFdhQm9Za3ZmMFZlOU0?oc=5\" target=\"_blank\">ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA</a>  Business Wire</li><li><a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxNQWJBamkwUUt5NWI4S25yYmZWdDFFenBxaWpocEFRMXd3WVdvUnMzQ0ZUR1RoeWdkd2U3aF8xQTdvaG1UYXV4R0FDclNrU0doRGoySlVQMGpXQU1EVkZ1c2lfa1V2NDhzTzRsYW1tOHBHeF9nWVJCZ3BtUGJHQkVPZU80UkFqaVIxb3lLbjlldW9jVG9E?oc=5\" target=\"_blank\">ImmunityBio tries again in papillary bladder cancer | ApexOnco - Clinical Trials news and analysis</a>  Oncology Pipeline</li><li><a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxQRm9LVkRpcGpWWEgyREZHdTl6dVdzQ0FDSEt4LU9nMWJNc2s0NlNLcGJvanlYNm1QUVdrQXhRel9aeEgtM2IwNzJ2dS05bWlENFdaWlpqWXNfZ1BmZ3RyWjhvSm9RNEFTTmhwNldKb1BJdWhLdTJnUVcySE1lb1h5UU8ySGxTdnMwbEFGeTlKMUdEcGp4MVUwSzdLX1VCemptN0RVMDJ5eTh5czhmYlVF?oc=5\" target=\"_blank\">Supplemental Information Requested For Nogapendekin Alfa sBLA in NMIBC Type</a>  CancerNetwork</li><li><a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxOX2JjZmtWQzNHckcxZDRXVXFqVHQzRXlxTkRwaHNTekZEM1MyZ19wMl9MdGhQQTZPLWRDYlYtRVkzeHdXUHN1ZlhVSVh6S1VpNUp0ZXdJbXJFelMzOGphMXRDMXVOZVVvdFU2WDVRWXN0R1doMlBvcnh6UW9DTjg0U0tvWGU2OXB4S1VEZXlxUWNMLUxFX3lzUDdWNmJMVUItWDVOUA?oc=5\" target=\"_blank\">Study progresses of nogapendekin alfa inbakicept for BCG-naïve NMIBC</a>  Urology Times</li><li><a href=\"https://news.google.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?oc=5\" target=\"_blank\">ImmunityBio Approval And Trial Updates Spark Valuation Debate For Investors</a>  simplywall.st</li>",
  "timestamp": 1768899600000,
  "source": "7f0afae8cac1",
  "category": ""
}